# Application of the STAAR framework in detecting rare variant associations with Alzheimer disease and related dementias: Insights and implications

**Authors:** Dongyu Wang, Sabrina Abbruzzese, Nancy Heard-Costa, Andy Rampersaud, Eden Martin, Adam Naj, Bilcag Akgun, Brian Kunkle, Sudha Seshadri, Gina Peloso, Anita L. DeStefano, Zilin Li, Xihao Li, Seung Hoan Choi

PMC · DOI: 10.1016/j.xhgg.2026.100574 · Human Genetics and Genomics Advances · 2026-01-20

## TL;DR

This study improves the STAAR framework to better detect rare genetic variants linked to Alzheimer's disease and related dementias using large-scale sequencing data.

## Contribution

The study introduces computational refinements to the STAAR framework to enhance its robustness in analyzing ultra-rare variants with dichotomous outcomes.

## Key findings

- Several genes were significantly associated with ADRD or cognitively healthy status before refinements.
- After refinements, associations for ZNF200 were no longer significant, while TBX19, PLXNB2, CARD11, and LINC01880 remained significant.
- The modified framework showed improved statistical validity and consistency in rare variant analyses.

## Abstract

Rare genetic variation is considered a potential source of heritability in individuals with sporadic Alzheimer disease and related dementias (ADRD). The Variant-set test for association using annotation information (STAAR) framework leverages multiple functional annotations of genetic variants and combines association statistics from multiple variant aggregation-based methods, including burden, sequence kernel association test (SKAT), and aggregated Cauchy association test (ACAT-V), into a single measure of significance. Using whole-genome sequencing data from the Alzheimer’s Disease Sequencing Project (ADSP), we comprehensively examined the association of rare genetic variation with ADRD in 23,454 individuals (37% individuals affected by ADRD) and with cognitively healthy elder status in 13,292 individuals (13% cognitively healthy elders) from diverse populations via the STAAR framework. We identified several genes significantly associated with ADRD or cognitively healthy status. However, our analysis revealed several limitations within the STAAR framework incorporating ultra-rare variants with dichotomous outcomes. To enhance the robustness of the framework, we proposed several computational refinements, including creating a burden of ultra-rare variants and employing more precise annotations to match the expected mechanism. After implementing the proposed modifications, the association with ADRD for ZNF200 was no longer statistically significant (α = 1 × 10−7), while TBX19, PLXNB2, CARD11, and LINC01880 remained significantly associated with cognitively healthy status. We identified and addressed the computational limitations in the STAAR framework that could lead to potential spurious results for ultra-rare variant aggregates with an extremely low cumulative minor-allele count. Our proposed refinements produced more robust results for associations with rare variants in the context of dichotomous outcomes.

In this study, we introduced a set of modifications to the STAAR framework to enhance its robustness in rare-gene-based analyses. The modified framework demonstrated improved statistical validity and consistency in identifying rare variant associations using whole-genome sequencing data from a large, diverse cohort.

## Linked entities

- **Genes:** ZNF200 (zinc finger protein 200) [NCBI Gene 7752], TBX19 (T-box transcription factor 19) [NCBI Gene 9095], PLXNB2 (plexin B2) [NCBI Gene 23654], CARD11 (caspase recruitment domain family member 11) [NCBI Gene 84433], LINC01880 (long intergenic non-protein coding RNA 1880) [NCBI Gene 105373979]
- **Diseases:** Alzheimer disease (MONDO:0004975)

## Full-text entities

- **Genes:** TBX19 (T-box transcription factor 19) [NCBI Gene 9095] {aka TBS19, TPIT, dJ747L4.1}, ZNF200 (zinc finger protein 200) [NCBI Gene 7752], CARD11 (caspase recruitment domain family member 11) [NCBI Gene 84433] {aka BENTA, BIMP3, CARMA1, IMD11, IMD11A, PPBL}, PLXNB2 (plexin B2) [NCBI Gene 23654] {aka MM1, Nbla00445, PLEXB2, dJ402G11.3, lncFAL}
- **Diseases:** Dementias (MESH:D003704), ADRD (MESH:D000544)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12934298/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12934298/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12934298/full.md

---
Source: https://tomesphere.com/paper/PMC12934298